Heat-induced apoptosis and p53 in cultured mammalian cells

International Journal of Radiation Biology

Volumn 71, Issue 5, 1997, Pages 519-529

  Nakano, H ^a   Kurihara, K ^a   Okamoto, M ^a   Tone S ^a   Shinohara, K ^b  

^a TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

APOPTOSIS; ARTICLE; CELL CULTURE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HYPERTHERMIA; PRIORITY JOURNAL;

APOPTOSIS; DNA FRAGMENTATION; GENES, P53; HEAT; HUMANS; TUMOR CELLS, CULTURED;

EID: 0030942595     PISSN: 09553002     EISSN: None     Source Type: Journal    
DOI: 10.1080/095530097143851     Document Type: Article

References (51)

1. AGER, D. D. and DEWY, W. C., 1990, Calibration of pulsed field gel electrophoresis for measurement of DNA double-strand breaks. International Journal of Radiation Biology, 58, 249-259.
2. ALBERTS, B., BRAY, D., LEWIS, J., RAFF, M., ROBERTS, K. and WATSON, J. D., 1989, In Molecular Biology of the Cell, 2nd ed. (New York: Garland Publishing), pp. 514-523.
3. ALLAN, D. J. and HARMON, B. V., 1986, The morphologic categorization of cell death induced by mild hyperthermia and comparison with death induced by ionizing radiation and cytotoxic drugs. Scanning Electron Microscopy, 3, 1121-1133.
4. BARBIERI, D., TROIANO, L., GRASSILLI, E., AGNESINI, C., CRISTOFALO, E. A., MONTI, D., CAPRI, M., COSSARIZZA, A. and FRANCESCHI, C., 1992, Inhibition of apoptosis by zinc: a reappraisal. Biochemical Biophysical Research Communications, 187, 1256-1261.
5. BARRY, M. A., BEHNKE, C. A. and EASTMAN, A., 1990, Activation of programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins and hyperthermia. Biochemical Pharmacology, 40, 2353-2362.
6. BICKNELL, G. R., SNOWDEN, R. T. and COHEN, G. M., 1994, Formation of high molecular mass DNA fragments is a marker of apoptosis in the human leukaemic cell line, U937. Journal of Cell Science, 107, 2483-2489.
7. BORTNER, C. D., OLDENBURG, N. B. E. and CIDLOWSKI, J. A., 1995, The role of DNA fragmentation in apoptosis. Trends in Cell Biology, 5, 21 27.
8. BROWN, D. G., SUN, X.-M. and COHEN, G. M., 1993, Dexamethasone-induced apoptosis involves cleavage of DNA to large fragments prior to internucleosomal fragmentation. The Journal of Biological Chemistry, 268, 3037-3039.
9. CHENG, J. and HAAS, M., 1990, Frequent mutation in the p53 tumor suppressor gene in human leukemia T-cell lines. Molecular and Cellular Biology, 10, 5502-5509.
10. CLARKE, A. R., PURDIE, C. A., HARRISON, D. J., MORRIS, R. G., BIRD, C. C., HOOPER, M. L. and WYLLIE, A. H., 1993, Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature, 362, 849-852.
11. COHEN, J. J. and DUKE, R. C., 1984, Glucocorticoid activation of a calcium-dependent endonuclease in thymocyte nuclei leads to cell death. The Journal of Immunology, 132, 38-42.
12. COHEN, G. M., SUN, X.-M., SNOWDEN, R. T., DINSDALE, D. and SKILLETER, D. N., 1992, Key morphological features of apoptosis may occur in the absence of internucleosomal DNA fragmentation. Biochemical Journal, 286, 331-334.
13. ENARI, M., TALANIAN, R. V., WONG, W. W. and NAGATA, S., 1996, Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis. Nature, 380, 723-726.
14. FLIPSKI, J., LEBLANC, J., YOUDALE, T., SIKORSKA, M. and WALKER, P. R., 1990, Periodicity of DNA folding in higher order chromatin structures. The EMBO Journal. 9, 1319-1327.
15. GANNON, J. V., GREAVES, R., IGGO, R. and LANE, D. P., 1990, Activating mutations in p53 produce a common conformational effect. A monoclonal antibody specific for the mutant form. The EMBO Journal, 9, 1595-1602.
16. HAN, T., PAULY, J. L. and MINOWADA, J., 1974, In vitro preferential effect of irradiation on cultured T lymphoid cell line. Clinical and Experimental Immunology, 17, 455-462.
17. HARMON, B. V., TAKANO, Y. S., WINTERFORD, C. M. and GOBÉ, G. C., 1991, The role of apoptosis in the response of cells and tumours to mild hyperthermia. International Journal of Radiation Biology, 59, 489-501.
18. JENKINS, J. R., RUDGE, K., CHUMAKOV, P. and CURRIE, G. A., 1985, The cellular oncogene p53 can be activated by mutagenesis. Nature, 317, 816-818.
19. KERN, S. E., PIETENPOL, J. A., THIAGALINGAM, S., SEYMOUR, A., KINZLER, K. W. and VOGELSTEIN, B., 1992, Oncogenic forms of p53 inhibit p53-regulated gene expression. Science, 256, 827-830.
20. KERR, J. F. R., WYLLIE, A. H. and CURRIE, A. R., 1972, Apoptosis: a basic biological phenomenon with wide ranging implications in tissue kinetics. British Journal of Cancer, 26, 239-257.
21. KUIDA, K., LIPPKE, J. A., KU, G., HARDING, M. W., LIVINGSTON, D. J., SU, M. S.-S. and FLAVELL, R. A., 1995, Altered cytokine export and apoptosis in mice deficient in Interleukin-1β converting enzyme. Science, 267, 2000-2003.
22. LAEMMLI, U. K., 1970, Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 227, 680-685.
23. LOTEM, J. and SACHS, L., 1993, Hematopoietic cells from mice deficient in wild-type p53 are more resistant to induction of apoptosis by some agents. Blood, 82, 1092-1096.
24. LOS, M., VAN DE CRAEN, M., PENNING, L. C., SCHENK, H., WESTENDORP, M., BAEUERLE, P. A., DRÖGE, W., KRAMMER, P. H., FIERS, W. and SCHULZE-OSTHOFF, K., 1995, Requirement of an ICE/CED-3 protease for Fas/ Apo-1-mediated apoptosis. Nature, 375, 81-83.
25. LOWE, S. W., SCHMITT, E. M., SMITH, S. W., OSBORNE, B. A. and JACKS, T., 1993, p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature, 362, 847-849.
26. MCGOWAN, A. J., FERNANDES, R. S., VERHAEGEN, S. and COTTER, T. G., 1994, Zinc inhibits UV radiation-induced apoptosis but fails to prevent subsequent cell death. International Journal of Radiation Biology, 66, 343-349.
27. MILNER, J. and MEDCALF, E. A., 1991, Cotranslation of activated mutant p53 with wild type derives the wild-type p53 protein into the mutant conformation. Cell, 65, 765-774.
28. MINOWADA, J., OHNUMA, T. and MOORE, G. E., 1972, Rosetteforming human lymphoid cell line. 1. Establishment and evidence for origin of thymus-derived lymphocytes. Journal of the National Cancer Institute, 49, 891-895.
29. MIURA, M., ZHU, H., ROTELLO, R., HARTWIEG, E. A. and YUAN, J., 1993, Induction of apoptosis in fibroblasts by IL-1β-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3. Cell, 75, 653-660.
30. NAKANO, H. and SHINOHARA, K., 1994, X-ray-induced cell death: apoptosis and necrosis. Radiation Research, 140, 1-9.
31. OBERHAMMER, F., WILSON, J. W., DIVE, C., MORRIS, I. D., HICKMAN, J. A., WAKELING, A. E., WALKER, P. R. and SIKORSKA, M., 1993, Apoptotic death in epithelial cells: cleavage of DNA to 300 and/or 50kb fragments prior to or in the absence of internucleosomal fragmentation. The EMBO Journal, 12, 3679-3684.
32. 1 hybrid mice. Carcinogenesis, 16, 2659-2666.
33. OREN, M., 1992, p53: the ultimate tumor suppressor gene? The FASEB Journal, 6, 3169-3176.
34. OREN, M., MALTZMAN, W. and LEVINE, A. J., 1981, Post-translational regulation of the 54K cellular tumor antigen in normal and transformed cells. Molecular and Cellular Biology, 1, 101-110.
35. ORMEROD, M. G., O'NEILL, C. F., ROBERTSON, D. and HARRAP, K. R., 1994, Cisplatin induces apoptosis in a human ovarian carcinoma cell line without concomitant internucleosomal degradation of DNA. Experimental Cell Research, 211, 231-237.
36. REICH, N. C. and LEVINE, A. J., 1984, Growth regulation of a cellular tumour antigen, p53, in nontransformed cells. Nature, 308, 199-201.
37. REICH, N. C., OREN, M. and LEVINE, A. J., 1983, Two distinct mechanisms regulate the levels of a cellular tumor antigen, p53. Molecular and Cellular Biology, 3, 2143-2150.
38. SATO, K. and HIEDA, N., 1979, Isolation and characterization of a mutant mouse lymphoma cell sensitive to methyl methanesulfonate and X rays. Radiation Research, 78, 167-171.
39. SHAW, P., BOVEY, R., TARDY, S., SAHLI, R., SORDAT, B. and COSTA, J., 1992, Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line. Proceedings of the National Academy of Sciences, USA, 89, 4495-4499.
40. SHINOHARA, K., KUGOTANI, M., ISHIWATA, J. and MATSUDA, T., 1987, Early change of adenosine triphosphate levels in L5178Y cells during hyperthermia. Japanese Journal of Cancer Research. 78, 333-335.
41. SHINOHARA, K. and MATSUDAIRA, H., 1976. Evidence for caffeine-sensitive damage in methylazoxymethanol acetate-treated L5178Y cells. Chemico-Biological Interactions, 12, 53-63.
42. SHINOHARA, K. and NAKANO, H., 1993. Interphase death and reproductive death in X-irradiated MOLT-4 cells. Radiation Research, 135, 197-205.
43. STRASSER, A., HARRIS, A. W., JACKS, T. and CORY, S., 1994, DNA damage can induce apoptosis in proliferating lymphoid cells via p53-independent mechanisms inhibitable by Bcl-2. Cell, 79, 329-339.
44. TOWBIN, H., STAEHELIN, T. and GORDEN, J., 1979, Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proceedings of the National Academy of Sciences, USA, 76, 4350-4354.
45. VASILAKOS, J. P., GHAYUR, T., CARROLL, R. T., GIEGEL, D. A., SAUNDERS, J. M., QUINTAL, L., KEANE, K. M. and SHIVERS, B. D., 1995, IL-1β converting enzyme (ICE) is not required for apoptosis induced by lymphokine deprivation in an IL-2-dependent T cell line. The Journal of Immunology, 155, 3433-3442.
46. WALKER, P. R., PANDEY, S. and SIKORSKA, M., 1995, Degradation of chromatin in apoptotic cells. Cell Death and Differentiation, 2, 97-104.
47. WALKER, P. R., SMITH, C., YOUDALE, T., LEBLANC, J., WHITFIELD, J. F. and SIKORSKA, M., 1991, Topoisomerase II-reactive chemotherapeutic drugs induce apoptosis in thymocytes. Cancer Research. 51, 1078-1085.
48. WYLLIE, A. H., 1980, Glucocorticoid-induced thymocyte apoptosis is associated with endonuclease activation. Nature, 284, 555-556.
49. WYLLIE, A. H., KERR, J. F. R. and CURRIE, A. R., 1980, Cell death: The significance of apoptosis. International Review of Cytology, 68, 251-306.
50. YOUNISH-ROUACH, E., RESNITZKY, D., LOTEM, J., SACHS, L., KIMCHI, A. and OREN, M., 1991, Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature, 352, 345-347.
51. ZHEN, W., DENAULT, C. M., LOVISCEK, K., WALTER, S., GENG, L. and VAUGHAN, A. T. M., 1995. The relative radiosensitivity of TK6 and WI-L2-NS lymphoblastoid cells derived from a common source is primarily determined by their p53 mutational status. Mutation Research. 346, 85-92.